Application

GENIXUS

Genixus, Corp.

Trademark/Service Mark Application, Principal Register

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)

Trademark/Service Mark Application, Principal Register

Serial Number: 90337589
Filing Date: 11/23/2020

The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 90337589
MARK INFORMATION
*MARK GENIXUS
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
LITERAL ELEMENT GENIXUS
MARK STATEMENT The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER Principal
APPLICANT INFORMATION
*OWNER OF MARK Genixus, Corp.
*MAILING ADDRESS 150 North Research Campus Drive
*CITY Kannapolis
*STATE
(Required for U.S. applicants)
North Carolina
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
28081
*EMAIL ADDRESS XXXX
LEGAL ENTITY INFORMATION
TYPE corporation
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION Delaware
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS 005 
*IDENTIFICATION Pharmaceutical preparations and substances for use in anesthesia, for the treatment and control of pain, and for the treatment and control of hypertension; Medical apparatus, namely, a drug delivery device prefilled with pharmaceutical products for use in anesthesia, for the treatment and control of pain, and for the treatment and control of hypertension; Pre-filled syringes containing pharmaceutical preparations for use in anesthesia, for the treatment and control of pain, and for the treatment and control of hypertension; Injectable pharmaceuticals for use in anesthesia, for the treatment and control of pain, and for the treatment and control of hypertension; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pre-filled syringes containing pharmaceutical preparations for the treatment of the aforementioned diseases and disorders and complications associated therewith
FILING BASIS SECTION 1(b)
INTERNATIONAL CLASS 040 
*IDENTIFICATION Contract manufacturing of pharmaceutical products; Contract manufacturing of pre-filled syringes containing pharmaceutical preparations; Manufacture, for others, of pharmaceutical and biopharmaceutical preparations
FILING BASIS SECTION 1(b)
INTERNATIONAL CLASS 042 
*IDENTIFICATION Scientific and medical research services; Pharmaceutical research services; Research and development of pharmaceutical products; Biotechnology research; Scientific research in the field of pharmacy; Scientific research into the development of new products; Testing services for assessing the efficacy and safety of pharmaceuticals; Preparation of reports relating to scientific research; Medical and scientific laboratory research and analysis; Development of products; Scientific and technological services in the field of pharmaceuticals and research and design relating thereto, namely, consulting and advisory services, CRO (Contract Research Organization) and CDMO (Contract Development and Manufacturing Organization) services; Industrial analysis and research services in the field of pharmaceuticals
FILING BASIS SECTION 1(b)
ATTORNEY INFORMATION
NAME Melissa A. Nowak
ATTORNEY DOCKET NUMBER GEXS-2-62968
ATTORNEY BAR MEMBERSHIP NUMBER XXX
YEAR OF ADMISSION XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY XX
FIRM NAME Christensen O'Connor Johnson Kindness
STREET 1201 Third Avenue, Suite 3600
CITY Seattle
STATE Washington
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
ZIP/POSTAL CODE 98101
PHONE 206-682-8100
FAX 206-224-0779
EMAIL ADDRESS efiling@cojk.com
OTHER APPOINTED ATTORNEY Jerald E. Nagae; Frances M. Jagla; Peter W. Becker; Makiko Coffland; George E. Renzoni, Ph.D.; John D. Denkenberger; Brandon C. Stallman; Laura A. Cruz; Ryan E. Dodge, Jr.; Brian W. Poor; Matthew D. Balint; Llewellyn Rhys Lawson; David P. Sheldon; Brian F. McMahon; B. Casey Fitzpatrick; Jadran Adrian Mihailovic; James Y. Go; Cory G. Claassen; Thomas S. (Stasiu) Nowak; and Juan Zheng, Ph.D
CORRESPONDENCE INFORMATION
NAME Melissa A. Nowak
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE efiling@cojk.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) NOT PROVIDED
FEE INFORMATION
APPLICATION FILING OPTION TEAS Standard
NUMBER OF CLASSES 3
APPLICATION FOR REGISTRATION PER CLASS 275
*TOTAL FEES DUE 825
*TOTAL FEES PAID 825
SIGNATURE INFORMATION
SIGNATURE /Melissa A. Nowak/
SIGNATORY'S NAME Melissa A. Nowak
SIGNATORY'S POSITION Attorney of record, Washington bar member
SIGNATORY'S PHONE NUMBER 206-682-8100
DATE SIGNED 11/23/2020



Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)


Trademark/Service Mark Application, Principal Register

Serial Number: 90337589
Filing Date: 11/23/2020

To the Commissioner for Trademarks:

MARK: GENIXUS (Standard Characters, see mark)
The literal element of the mark consists of GENIXUS. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, Genixus, Corp., a corporation of Delaware, having an address of
      150 North Research Campus Drive
      Kannapolis, North Carolina 28081
      United States
      XXXX

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

International Class 005:  Pharmaceutical preparations and substances for use in anesthesia, for the treatment and control of pain, and for the treatment and control of hypertension; Medical apparatus, namely, a drug delivery device prefilled with pharmaceutical products for use in anesthesia, for the treatment and control of pain, and for the treatment and control of hypertension; Pre-filled syringes containing pharmaceutical preparations for use in anesthesia, for the treatment and control of pain, and for the treatment and control of hypertension; Injectable pharmaceuticals for use in anesthesia, for the treatment and control of pain, and for the treatment and control of hypertension; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pre-filled syringes containing pharmaceutical preparations for the treatment of the aforementioned diseases and disorders and complications associated therewith
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

International Class 040:  Contract manufacturing of pharmaceutical products; Contract manufacturing of pre-filled syringes containing pharmaceutical preparations; Manufacture, for others, of pharmaceutical and biopharmaceutical preparations
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

International Class 042:  Scientific and medical research services; Pharmaceutical research services; Research and development of pharmaceutical products; Biotechnology research; Scientific research in the field of pharmacy; Scientific research into the development of new products; Testing services for assessing the efficacy and safety of pharmaceuticals; Preparation of reports relating to scientific research; Medical and scientific laboratory research and analysis; Development of products; Scientific and technological services in the field of pharmaceuticals and research and design relating thereto, namely, consulting and advisory services, CRO (Contract Research Organization) and CDMO (Contract Development and Manufacturing Organization) services; Industrial analysis and research services in the field of pharmaceuticals
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.



The owner's/holder's proposed attorney information: Melissa A. Nowak. Other appointed attorneys are Jerald E. Nagae; Frances M. Jagla; Peter W. Becker; Makiko Coffland; George E. Renzoni, Ph.D.; John D. Denkenberger; Brandon C. Stallman; Laura A. Cruz; Ryan E. Dodge, Jr.; Brian W. Poor; Matthew D. Balint; Llewellyn Rhys Lawson; David P. Sheldon; Brian F. McMahon; B. Casey Fitzpatrick; Jadran Adrian Mihailovic; James Y. Go; Cory G. Claassen; Thomas S. (Stasiu) Nowak; and Juan Zheng, Ph.D. Melissa A. Nowak of Christensen O'Connor Johnson Kindness, is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located at
      1201 Third Avenue, Suite 3600
      Seattle, Washington 98101
      United States
      206-682-8100(phone)
      206-224-0779(fax)
      efiling@cojk.com
The docket/reference number is GEXS-2-62968.
Melissa A. Nowak submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S. Commonwealth or territory.
The applicant's current Correspondence Information:
      Melissa A. Nowak
       PRIMARY EMAIL FOR CORRESPONDENCE: efiling@cojk.com       SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): NOT PROVIDED


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $825 has been submitted with the application, representing payment for 3 class(es).

Declaration

Declaration Signature

Signature: /Melissa A. Nowak/   Date: 11/23/2020
Signatory's Name: Melissa A. Nowak
Signatory's Position: Attorney of record, Washington bar member
Payment Sale Number: 90337589
Payment Accounting Date: 11/23/2020

Serial Number: 90337589
Internet Transmission Date: Mon Nov 23 17:27:57 ET 2020
TEAS Stamp: USPTO/BAS-XX.XX.XXX.XXX-2020112317275767
4718-90337589-7506b2669d1c33a8dda8275fec
271fe7fed6e4d8a4f658dcfced1ea75a4f231c4c
-CC-27556002-20201123143852719606

Application [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed